226 related articles for article (PubMed ID: 26179261)
81. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.
Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z
Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189
[TBL] [Abstract][Full Text] [Related]
82. Prognostic potential of miR-21-3p in gastric cancer.
Sun X; Zhang K; Li D
J BUON; 2020; 25(6):2678-2682. PubMed ID: 33455113
[TBL] [Abstract][Full Text] [Related]
83. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
84. miR-488 acts as a tumor suppressor gene in gastric cancer.
Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
[TBL] [Abstract][Full Text] [Related]
85. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
[TBL] [Abstract][Full Text] [Related]
86. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
[TBL] [Abstract][Full Text] [Related]
87. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
88. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
89. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
90. Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer.
Chen X; Liu XS; Liu HY; Lu YY; Li Y
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173244
[TBL] [Abstract][Full Text] [Related]
91. Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients.
Ng EK; Leung CP; Shin VY; Wong CL; Ma ES; Jin HC; Chu KM; Kwong A
PLoS One; 2011; 6(7):e22233. PubMed ID: 21789241
[TBL] [Abstract][Full Text] [Related]
92. Analysis of 8q24.21 miRNA cluster expression and copy number variation in gastric cancer.
Anauate AC; Leal MF; Wisnieski F; Santos LC; Gigek CO; Chen ES; Calcagno DQ; Assumpção PP; Demachki S; Arasaki CH; Artigiani R; Rasmussen LT; Payão SM; Burbano RR; C Smith MA
Future Med Chem; 2019 May; 11(9):947-958. PubMed ID: 31141411
[No Abstract] [Full Text] [Related]
93. Dysregulation of miR-195-5p/-218-5p/BIRC5 axis predicts a poor prognosis in patients with gastric cancer.
Zou J; Liao X; Zhang J; Wang L
J Biol Regul Homeost Agents; 2019; 33(5):1377-1385. PubMed ID: 31663299
[TBL] [Abstract][Full Text] [Related]
94. CircRNA
Li R; Tian X; Jiang J; Qian H; Shen H; Xu W
Biomarkers; 2023 Dec; 28(5):448-457. PubMed ID: 37128800
[TBL] [Abstract][Full Text] [Related]
95. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker.
Zhou H; Guo JM; Lou YR; Zhang XJ; Zhong FD; Jiang Z; Cheng J; Xiao BX
J Mol Med (Berl); 2010 Jul; 88(7):709-17. PubMed ID: 20349219
[TBL] [Abstract][Full Text] [Related]
96. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
[TBL] [Abstract][Full Text] [Related]
97. Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.
Han J; Lv P; Yu JL; Wu YC; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Dig Dis Sci; 2014 Jun; 59(6):1160-8. PubMed ID: 24385013
[TBL] [Abstract][Full Text] [Related]
98. Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis.
Zhu X; Lv M; Wang H; Guan W
Dig Dis Sci; 2014 May; 59(5):911-9. PubMed ID: 24337687
[TBL] [Abstract][Full Text] [Related]
99. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
[TBL] [Abstract][Full Text] [Related]
100. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.
Wang JL; Hu Y; Kong X; Wang ZH; Chen HY; Xu J; Fang JY
PLoS One; 2013; 8(9):e73683. PubMed ID: 24040025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
